Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Fax+1 216-839-2975
Dr. Koc is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1996
Cleveland Clinic FoundationResidency, Internal Medicine, 1989 - 1992
Istanbul University FomClass of 1987
Certifications & Licensure
OH State Medical License 1991 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma Start of enrollment: 2001 Mar 01
- Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma Start of enrollment: 2000 Jun 01
- Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2002 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Lenalidomide, rituximab (R), and ixazomib for frontline treatment of high risk follicular and indolent non-Hodgkin lymphoma.Brian T Hill, Yanwen Chen, Deepa Jagadeesh, Robert Dean, Omer Koc
Leukemia & Lymphoma. 2024-06-01 - 13 citationsPazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.Joseph Parambil, Troy D. Woodard, Omer N. Koc
The Laryngoscope. 2018-10-01 - 17 citationsPhase I Trial of the Combination of Flavopiridol and Imatinib Mesylate in Patients with Bcr-Abl+ Hematological MalignanciesPrithviraj Bose, Edward B. Perkins, Connie Honeycut, Martha D. Wellons, Tammy Stefan
Cancer Chemotherapy and Pharmacology. 2012-02-15
Grant Support
- Flavopiridol + Imatinib Mesylate In Chromosome Positive LeukemiaNational Center For Research Resources2005
- Hematopoietic Stem Cell FacilityNational Center For Research Resources2004–2005
- Flavopiridol + Imatinib Mesylate In BCR/ABL+ Hematologic MalignanciesNational Center For Research Resources2004
- Donor Mesenchymal Stem Cell Infusion For Treatment Of Genetic DisordersNational Center For Research Resources2000–2002
- Therapeutic Uses Of Human Mesenchymal Stem CellsNational Heart, Lung, And Blood Institute1999–2002
- Transplantation Of Allogeneic Mesenchymal Stem CellsNational Cancer Institute1999–2000
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
